32
Views
0
CrossRef citations to date
0
Altmetric
Research

Rationales and arguments behind the adoption of self-selection of nonprescription medicines in Denmark

ORCID Icon, &
Article: 29 | Received 17 Dec 2019, Accepted 18 May 2020, Published online: 04 Dec 2023

References

  • Vogler S, Habimana K, Arts D. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries. Health Policy. 2014;117:311–27.
  • Martins SF, van Mil JW, da Costa FA. The organizational framework of community pharmacies in Europe. Int J Clin Pharmacol. 2015;37:896–905.
  • Medicines Act 1968 (UK).
  • Läkemedelsverkets föreskrifter om detaljhandel vid öppenvårdsapotek [the Swedish medical products Agency’s regulations on retailing at pharmacies]: LVFS 2009. Uppsala: Läkemedelsverket [The Swedish Medical Products Agency]; 2009. p. 9.
  • Lag (2009:730) om handel med vissa receptfria läkemedel [act (2009: 730) on sales of certain nonprescription medicines]: Svensk författningssamling 2009. Stockholm: Socialdepartementet [Ministry of Health and Social Affairs]; 2009. p. 730.
  • Forskrift om apotek (apotekforskriften) [the Norwegian pharmacy act]: FOR-2001-02-26-178. Oslo: Helse- og omsorgsdepartementet [Ministry of Health and Care]; 2001.
  • Forskrift om endring i forskrift om omsetning mv. Av visse reseptfrie legemidler utenom apotek [amendment to the Norwegian act on turnover etc. of certain nonprescription medicines outside pharmacies]: FOR-2010-12-20-1713. Oslo: Helse- og omsorgsdepartementet [Ministry of Health and Care]; 2015.
  • Forslag til Lov om ændring af lov om apotekervirksomhed og lov om lægemidler [proposed amendment to the Danish pharmacy act and the Danish medicines act]: 2016/1 LSF 38. København: Sundheds- og Ældreministeriet [Ministry of Health]; 2016.
  • Almarsdottir AB, Traulsen JM. Multimethod research into policy changes in the pharmacy sector--the Nordic case. Res Social Adm Pharm. 2009;5:82–90.
  • Larsen JB, Vrangbæk K, Traulsen JM. Advocacy coalitions and pharmacy policy in Denmark—solid cores with fuzzy edges. Soc Sci Med. 2006;63:212–24.
  • Danish Medicines Agency. Over the counter medicine in self-selection. København: Danish Medicines Agency; [updated 2019 Apr 03; cited 2019 Dec 09]. Available from: https://laegemiddelstyrelsen.dk/en/pharmacies/over-the-counter-medicines/over-the-counter-medicine-in-self-selection/.
  • Danmarks Apotekerforening [The Associations of Danish Pharmacies]. Udligning [equalization]. København: Danmarks Apotekerforening; 2017. [cited 2018 Jul 18]. Available from: https://www.apotekerforeningen.dk/om-os/regulering-af-apotekerne/udligning.
  • Danmarks Apotekerforening [The Associations of Danish Pharmacies]. Lægemidler i Danmark 2018–19 [medicines in Denmark 2018–19]. København: Danmarks Apotekerforening; 2019. [cited 2020 Apr 30]. Available from: https://www.apotekerforeningen.dk/-/media/apotekerforeningen/stoerre_publikationer/laegemidler-i-danmark-2018-2019.pdf.
  • Folketinget [The Danish Parliament]. Lovgivningsprocessen i Folketinget [the legislative process in the Danish parliament]. København: Folketinget. [cited 2018 Feb 28]. Available from: http://www.ft.dk/da/folkestyret/folketinget/lovgivningsprocessen-i-folketinget.
  • Folketinget [The Danish Parliament]. Sagsforløb: L 38 Forslag til lov om ændring af lov om apotekervirksomhed og lov om lægemidler [proceedings: L 38 proposed amendment to the Danish pharmacy act and the Danish medicines act]. København: Folketinget. [cited 2018 Jul 22]. Available from: https://www.ft.dk/samling/20161/lovforslag/l38/index.htm.
  • Bowen GA. Document analysis as a qualitative research method. Qual Res J. 2009;9:27–40.
  • Traulsen JM, Kaae S. Qualitative methods in pharmacy practice research. In: Baber Z, editor. Pharmacy Preactice research methods. Auckland: Springer International Publishing AG Switzerland/Springer Science+Business Media; 2015. p. 49–68.
  • Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42:533–44.
  • Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–88.
  • Björnsson G, Kihlbom U, Ullholm A. Beviskraft, hållbarhet och relevans [probative force, validity and relevance]. In: Björnsson G, Kihlbom U, Ullholm A, editors. Argumentationsanalys: Färdigheter för kritiskt tänkande [argumentation analysis: skills for critical thinkers]. Stockholm: Natur & Kultur; 2009. p. 21–4.
  • Bekendtgørelse om apoteker og sygehusapotekers driftsforhold [executive order on pharmacies’ and hospital pharmacies’operating conditions]: BEK nr 1356 af 29/11/2017. København: Sundheds- og Ældreministeriet [Ministry of Health]; 2017. Available from: https://www.retsinformation.dk/Forms/R0710.aspx?id=195089.
  • Bekendtgørelse om forhandling af håndkøbslægemidler uden for apotek [executive order on non-pharmacy sales of nonprescription medicines]: BEK nr 1274 af 27/11/2017. København: Sundheds- og Ældreministeriet [Ministry of Health]; 2017. Available from: https://www.retsinformation.dk/Forms/R0710.aspx?id=194990.
  • Läkemedelsverket [The Swedish Medical Products Agency]. Försäljning av paracetamol i tablettform i detaljhandeln upphör 1 november [non-pharmacy sales of paracetamol ends 1 November]. Uppsala: Läkemedelsverket; 2015. [updated 2015 Apr 29; cited 2018 Feb 22]. Available from: https://lakemedelsverket.se/Alla-nyheter/NYHETER-2015/Forsaljning-av-paracetamol-i-tablettform-i-detaljhandeln-upphor-1-november/.
  • Schytte-Hansen S. Danskerne og håndkøbslægemidler - opfattelse, adfærd, holdninger [Danes and nonprescription medicines – perception, behaviour, attitudes]. København: Danmarks Farmaceutiske Universitet; 2003.
  • Westerlund LT, Marklund BR, Handl WH, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother. 2001;35:1343–9.
  • Bolvig T, Frøkjær B, Herborg H, Rossing C. Forekomsten af lægemiddelrelaterede problemer ved selvmedicinering [the incidence of drug-related problems in self-medication]. Hillerød: Pharmakon; 2011 Available from: https://www.apotekerforeningen.dk/~/media/Apotekerforeningen/stoerre_publikationer/lm_relaterede_probl_selvmedicinering_2011.ashx.
  • Eickhoff C, Hämmerlein A, Griese N, Schulz M. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf. 2012;21:254–60.
  • Sclar DA, Robison LM, Skaer TL. Pharmacy consultation and over-the-counter medication purchasing outcomes. Over-the-counter medication intervention project team. J Clin Pharm Ther. 1996;21:177–84.
  • Chandon P, Hutchinson JW, Bradlow ET, Young SH. Does in-store marketing work? Effects of the number and position of shelf facings on brand attention and evaluation at the point of purchase. J Mark. 2009;73:1–17.
  • Folketinget [The Danish Parliament]. L 38 Forslag til lov om ændring af lov om apotekervirksomhed og lov om lægemidler: Spørgsmål [L 38 proposed amendment to the Danish pharmacy act and the Danish medicines act: questions]. København: Sundheds- og Ældreudvalget; 2016. [updated 2016 Dec 12; cited 2018 Jul 23]. Available from: https://www.ft.dk/samling/20161/lovforslag/L38/spm.htm.
  • Wisell K, Winblad U, Sporrong SK. Reregulation of the Swedish pharmacy sector - a qualitative content analysis of the political rationale. Health Policy. 2015;119:648–53.
  • Apotekforeningen [Norwegian Pharmacy Association]. 1.1 Apotek i Norge [1.1 pharmacy in Norway]. Oslo: Apotekforeningen; 2017. [cited 2018 Jul 18]. Available from: http://www.apotek.no/fakta-og-ressurser/statistikk-for-2016/1%2D%2Dapotek/1-1-apotek-i-norge.
  • Danmarks Apotekerforening [The Association of Danish Pharmacies]. Bruttoavance [gross profit]. København: Danmarks Apotekerforening; 2017. [cited 2018 Jul 18]. Available from: https://www.apotekerforeningen.dk/om-os/regulering-af-apotekerne/bruttoavance.
  • Hansen HF, Rieper O. Evidenspolitik - fallet Danmark [evidence politics – the case of Denmark]. In: Bohlin I, Sager M, editors. Evidensens många ansikten: evidensbaserad praktik i praktiken [the many faces of evidence: evidence-based practice in practice]. Lund: Arkiv förlag & tidskrift; 2011. p. 185–205.
  • van der Pas D. Making Hay while the sun shines: do parties only respond to media attention when the framing is right? Int J Press Polit. 2013;19:42–65.
  • Hiilamo H, Kangas O. Trap for women or freedom to choose? The struggle over cash for child care schemes in Finland and Sweden. J Soc Policy. 2009;38:457–75.
  • Sabatier PA, Weible CM. The advocacy coalition framework: innovations and clarifications. In: Sabatier PA, editor. Theories of the policy process. Colorado: Westview Press; 2007. p. 189–220.
  • Lluch M, Kanavos P. Impact of regulation of community pharmacies on efficiency, access and equity. Evidence from the UK and Spain. Health Policy. 2010;95:245–54.
  • Wisell K, Winblad U, Sporrong SK. Stakeholders’ expectations and perceived effects of the pharmacy ownership liberalization reform in Sweden: a qualitative interview study. BMC Health Serv Res. 2016;16:379.
  • Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy. 2005;75:9–17.
  • The Danish National Committee on Health Research Ethics. Act on research ethics review of Health Research projects. Copenhagen: The Danish National Committee on Health Research Ethics; 2011. Jun [cited 2019 Nov 13]. Available from: http://en.nvk.dk/rules-and-guidelines/act-on-research-ethics-review-of-health-research-projects.